The increasing off-label use of tirzepatide for cosmetic weight loss, particularly in patients without metabolic disease, underscores the need for vigilant post-marketing surveillance
One way or another, many experts in the field say, its sensible to cover weight loss before the onset of the chronic illnesses associated with obesity, like Type 2 diabetes
Some animal studies suggest weight reduction may partially restore lymphatic function
[3] Step Therapy Exception If you've tried and failed a preferred drug in the last 180 days, or have documented contraindications to all preferred drugs, you may qualify for Zepbound without repeating step therapy
As of this writing, that reporting could not be independently verified against a primary FDA.gov source, no ipamorelin-specific Pharmacy Compounding Advisory Committee hearing date had been confirmed, and the formal notice-and-comment rulemaking needed to finalize any Category 1 listing has not been confirmed as complete